🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07090772
Enrolling by invitation Not applicable

The Effectiveness of Different Therapeutic Jaw Position Determining Methods in Repositioning Splint Therapy for Temporomandibular Joint Disk Displacement Without Reduction:A Randomized Controlled Clinical Trial

NCT07090772 · tracked via the Priya Life Science China tracker
Sponsor
Fujian Medical University
Phase
Not applicable
Started
2025-07-20
Last updated
2025-07-29

Condition(s) studied

Temporomandibular Disorder (TMD)

Investigational drug(s) / intervention(s)

Repositioning splint therapy with jaw position determined by mechanical articulatorRepositioning splint therapy with jaw position determined by ai-assisted virtual articulatorRepositioning splint therapy with jaw position determined by ai-assisted virtual patient

Repositioning splint therapy with jaw position determined by mechanical articulator: The therapeutic jaw position will be determined by the following steps: 1. Pre-treatment Jaw Position Recording Participants were seated upright with relaxed posture, eyes facing forward, and the Frankfort plane parallel to the floor. Intercuspal position (ICP) was recorded using silicone registration material. Edge-to-edge position of central incisors was recorded for protrusive position. Left/right lateral positions were recorded with opposing canines aligned. 2. Transfer of Jaw Positions Following the manufacturer's protocol for the Artex CR mechanical facebow (Amann Girrbach, Austria) to transfer Participants' jaw positions. 3. Determination of Therapeutic Position The Glenoid fossa was divided into 7 grids in the oblique-sagittal plane using Gelb's method, identifying grid 4 (Gelb 4/7) as the target condylar position.Condylar displacement knobs were set per VTO analysis. Incisal pin height was increased to establish vertical dimension.

Repositioning splint therapy with jaw position determined by ai-assisted virtual articulator: The jaw position was determined by the following steps: 1. AI-Based Segmentation and Reconstruction of Jaw Models CBCT DICOM data was imported into an ai-based craniomaxillofacial bone segmentation system to reconstruct 3D models of the jaws and dentition. The mandibular/maxillary bone models and dental arches were exported as .ply files. These .ply files were then imported into Exocad software. 2. Virtual Transfer of Jaw Positions Bilateral AI-segmented medial pole points of the condyles and the right infraorbital point were annotated in cross-sectional views.A virtual articulator was added and registered to the facebow's reference planes and hinge axis. (3)Determination of Therapeutic Position Sagittal joint spaces (anterior/superior/posterior) were measured on cross-sectional views. The composite mandibular model was repositioned to the target occlusion using the "Move Mesh" function based on: Optimal mean joint space measurements and physiological condylar position.

Repositioning splint therapy with jaw position determined by ai-assisted virtual patient: The jaw position was determined by the following steps: 1. AI-Based Segmentation and Reconstruction of Virtual Patients: CBCT DICOM data was imported into an ai-based craniomaxillofacial bone segmentation system to reconstruct 3D models of the jaws and dentition. The trajectory of mandibular movement was recorded by an electronic facebow. 2. Virtual Transfer of Jaw Positions Bilateral AI-segmented medial pole points of the condyles and the right infraorbital point were annotated in cross-sectional views.A virtual articulator was added and registered to the facebow's reference planes and hinge axis. (3)Determination of Therapeutic Position Sagittal joint spaces (anterior/superior/posterior) were measured on cross-sectional views. The therapeutic position was determined based on: Optimal mean joint space measurements, physiological condylar position and optimal trajectory of mandibular movement.

Study summary

The goal of this clinical trial is to learn if different therapeutic jaw position determining methods influence the efficacy of repositioning splint therapy for temporomandibular joint disk displacement without reduction. The main questions it aims to answer are:

Does different therapeutic jaw position determining methods influence the efficacy of repositioning splint therapy for temporomandibular joint disk displacement without reduction? Researchers will compare the efficacy of repositioning splint therapy made with different therapeutic jaw position determining methods for temporomandibular joint disk displacement without reduction.

Participants will:

Take repositioning splint made with different therapeutic jaw position determining methods every day for 3-6 months.

Visit the clinic once every 3 weeks for checkups and tests.

Eligibility

Sex
ALL
Min age
13 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 13-50 years, with permanent dentition, possessing full autonomy in behavior and expression; * Meeting the 2014 Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) diagnostic standards for irreducible temporomandibular joint disc displacement; * MRI-confirmed unilateral irreducible disc displacement: At maximum intercuspation: Posterior band of disc located anterior to the 11:30 position, intermediate zone anterior to condyle; At maximum mouth opening: Intermediate zone remains anterior to condyle. Exclusion Criteria: * Systemic diseases, psychiatric disorders, or impaired consciousness; * Pain-only disorders without articular pathology signs; * Mandibular hypoplasia, TMJ tumors, or prior TMJ trauma; * History of definitive TMJ disorder treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fujian Medical University Fuzhou Fujian

More Fujian Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07090772 on ClinicalTrials.gov ↗ ← All trials in China